Company: SUZ
Filing Date: 2025-08-07
Form Type: 6-K
Source: 0000909327-25-000014
Chunk: 4

Company: Suzano S.A.
Filing Date: 2025-08-07
Form: 6-K
Chunk 4
---
     |       |                   |
| Bem Agro Integração e Desenvolvimento S.A. (Indirect)                    |     | Software solutions based on artificial intelligence and computer vision for agribusiness |     | Brazil                   |     |  5.82 | %          |     |  5.82 | %                 |
| Celluforce Inc. (Direct)                                                 |     | Nanocrystalline pulp research and development                                            |     | Canada                   |     |  8.28 | %          |     |  8.28 | %                 |
| Lenzing Aktiengesellschaft (Indirect)                                    |     | Production of wood-based cellulose fibers                                                |     | Austria                  |     | 15.00 | %          |     | 15.00 | %                 |
| Nfinite Nanotechnology Inc. (Indirect)                                   |     | Research and development of smart nanocoatings                                           |     | Canada                   |     |  4.90 | %          |     |  5.00 | %                 |

(1) On April 4, 2025, Biomas Serviços Ambientais, Restauração e Carbono S.A acquired Muçununga Serviços Ambientais, Restauração e Carbono Ltda. as a wholly owned subsidiary (100% of participation shares), which is an indirect subsidiary of Suzano S.A.

1.2 Major events in the six-month period ended June 30, 2025

1.2.1 Acquisition of an interest in a global tissue business

On June 5, 2025, the Company announced that its wholly owned subsidiary, Suzano International Holding B.V., incorporated in the Netherlands, entered into an Equity and Asset Purchase Agreement with Kimberly-Clark Corporation (“K-C”) for the acquisition of 51% equity interest (the “Transaction”) in a newly formed company in the Netherlands (“Target Company”).

The Transaction involves the acquisition of assets and businesses related to the manufacturing, marketing, distribution, and sale of tissue products in selected jurisdictions across the Americas, Europe, Asia, Africa, and Oceania. The Transaction includes 22production facilities located in 14countries. In addition, certain regional brands will be transferred to the Target Company, and certain global brands will be licensed by K-C to the Target Company in the relevant regions on a royalty-free, long-term basis.

K-C will retain the remaining 49% ownership interest in the Target